Persistent mesodermal differentiation capability of bone marrow mscs isolated from aging patients with low-energy traumatic hip fracture and osteoporosis: a clinical evidence

HIGHLIGHTS

• What: The authors aimed to collect BMSCs from clinical patients with followed by osteogenic differentiation comparison with BMSCs from healthy young donors. Patients recruited in this study were older than 50 years with low-energy hip fractures, and all patients` Informed Consent Forms (ICFs) were collected before the study. Echoing the findings and hBMSCs bank established in the present study, all novel compounds developed in the above publications can be examined and screened again in the hBMSCs derived from aging osteoporotic patients to clarify a long-termed controversial issue of whether hBMSCs withdrew from the osteoporotic patients . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.